
P1639: UTILITY OF NEXT GENERATION SEQUENCING TECHNIQUES TO EVALUATE POSSIBLE CAUSES OF REFRACTORINESS TO TREATMENT WITH ELTROMBOPAG IN ADULT PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA (ITP) IN SPAIN.
Author(s) -
GonzalezLopez T. J.,
Sanchez R.,
Pastoriza C.,
Sanchez Gonzalez B.,
Olivera P.,
Bernat S.,
FernandezFuertes F.,
Caparrós Miranda I.,
Mingot E.,
PérezRus G.,
Jarque I.,
Moreno Beltrán M. E.,
López Abadía E.,
De Cabo E.,
Marcellini S.,
Pérez Segura G.,
FernándezMiñano C.,
Peñarrubia M. J.,
Alvarez M.,
Fuertes Palacio M. A.,
Martinez Lopez J.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000849412.72733.8d
Subject(s) - eltrombopag , thrombopoietin , refractory (planetary science) , medicine , refractory period , romiplostim , immunology , platelet , immune thrombocytopenia , gastroenterology , pharmacology , biology , haematopoiesis , genetics , stem cell , astrobiology